Jörg Ermisch

Urinary Peptides Significantly Associate with COVID‐19 Severity: Pilot Proof‐of‐Principle Data and Design of a Multicentric Diagnostic Study

H. Mischak, J. Metzger, C. Lübbert, 2020, Proteomics.

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study

A. Mebazaa, Bjoern Peters, J. Staessen, 2022, The Lancet Digital Health.

Unhappy Triad: Infection with Leptospira spp. Escherichia coli and Bacteroides uniformis Associated with an Unusual Manifestation of Portal Vein Thrombosis

C. Lübbert, S. Kalbitz, Jörg Ermisch, 2021, Case Reports in Gastroenterology.

Unhappy Triad: Infection with Leptospira spp. Escherichia coli and Bacteroides uniformis Associated with an Unusual Manifestation of Portal Vein Thrombosis

C. Lübbert, S. Kalbitz, Jörg Ermisch, 2021 .

Differences of SARS-CoV-2 serological test performance between hospitalized and outpatient COVID-19 cases

B. Isermann, T. Kaiser, O. Nickel, 2020, Clinica Chimica Acta.